Nanosonics Ltd (NAN) – NEUTRAL
Nanosonic (NAN) reported as expected FY18 results. Key results highlights were: (1) Total sales of $60.7m were down -10%
Analyst Research
Biotechnology
Analyst Research
CSL Limited (CSL) – BUY
CSL continues to deliver pleasing results, coming in slightly ahead of guidance posted in May, with FY18 earnings